Pia W. R.
- Country
- Austria
- Department
- University Clinic for Gynecology and Obstetrics
Research Overview
- Phase III Randomized Double-Blind Placebo-Controlled Trial of Letrozole Maintenance Therapy in Epithelial Ovarian Cancer Post-Surgery and Chemotherapy
- A Phase III, randomized, multi-site, open-label trial of BNT323/DB-1303 versus investigator’s choice of chemotherapy in previously treated patients with HER2- expressing recurrent endometrial cancer
Data & Insights
Has run more than one trial at 7 of 117 partner sites.
Specializations
Gynecologic Oncology and Breast Cancer
Clinical trial activity includes the management of advanced breast cancer, early breast cancer, and triple-negative breast cancer, together with studies in endometrial cancer, metastatic cervical cancer, and epithelial ovarian cancer.
- HER2-positive and hormone receptor-positive breast cancer
- Metastatic cervical cancer and endometrial cancer
- Ovarian cancer and other solid tumors
Therapeutic interest extends to targeted and immunologic approaches used in recurrent, unresectable, and metastatic female malignancies.
Inflammatory Bowel Disease and Immune-Mediated Disorders
The investigator is involved in studies across Crohn’s disease, ulcerative colitis, atopic dermatitis, lupus nephritis, and systemic lupus erythematosus, reflecting a strong focus on chronic immune-driven disease.
- Crohn’s disease and ulcerative colitis
- Atopic dermatitis
- Lupus nephritis and systemic lupus erythematosus
Research activity also includes chronic rhinosinusitis with nasal polyps and other inflammatory conditions requiring long-term disease control.
Hematologic Malignancies and Pediatric Oncology
Clinical research spans acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndrome, multiple myeloma, and a broad range of childhood and adolescent cancers.
- Acute leukemias in adults and children
- Lymphoma and multiple myeloma
- Neuroblastoma, medulloblastoma, and ependymoma
Additional involvement includes malignant germ cell tumors, Ewing sarcoma, and rhabdomyosarcoma, with attention to high-risk and relapsed disease.
Neurology, Epilepsy, and Neurodevelopment
The investigator contributes to trials in focal seizures, primary generalized tonic-clonic seizures, refractory status epilepticus, and early Parkinson’s disease, along with cognitive and neuropsychiatric conditions.
- Epilepsy and refractory status epilepticus
- Parkinson’s disease and schizophrenia
- Alzheimer’s disease and mild cognitive impairment
Research also includes narcolepsy with cataplexy and sudden sensorineural hearing loss with neurological relevance.
Cardiometabolic, Pulmonary, and Rare Disease Research
Trial involvement covers heart failure, atrial fibrillation, hypertension, obesity, type 2 diabetes, chronic kidney disease, and cystic fibrosis, alongside selected rare disorders.
- Cardiovascular disease and heart failure
- Obesity, type 2 diabetes, and hypertension
- Idiopathic pulmonary fibrosis and cystic fibrosis
Additional areas include epidermolysis bullosa, Fabry disease, AL amyloidosis, and macular edema associated with retinal vascular disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.